Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty in connection with the proposed acquisition of Eclipsys Corporation (NASDAQ: ECLP) (referred to as "Eclipsys" or the “Company”) by Allscripts-Misys Healthcare Solutions, Inc. (NASDAQ: MDRX) (referred to as "Allscripts") in an all-stock transaction valued at approximately $1.3 billion.

The merger agreement has been approved by the Board of Directors of both Allscripts and Eclipsys. Under terms of the merger agreement, Eclipsys stockholders will receive 1.2 shares of Allscripts for each share of Eclipsys.

The merger will be subject to stockholder approvals from both Allscripts and Eclipsys, and other closing conditions and regulatory approvals, including expiration or termination of any applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.

Bull & Lifshitz, LLP's investigation is focused on whether the proposed deal provides adequate value to the Company’s shareholders.

If you are a holder of Eclipsys stock and want to discuss your legal rights, you may e-mail or call Bull & Lifshitz, LLP who will, without obligation or cost to you, attempt to answer your questions.

If you are a shareholder of Eclipsys and would like more information about our investigation, please contact Peter D. Bull, Esq. by telephone at (866) 313-6222 or by sending an e-mail including your contact information to: counsel@nyclasslaw.com. All e-mail correspondence should make reference to Eclipsys.

Bull & Lifshitz, LLP is a New York City-based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions. For more information about the firm, please visit our website at www.nyclasslaw.com.

ATTORNEY ADVERTISING. © 2010 Bull & Lifshitz, LLP. The law firm responsible for this advertisement is Bull & Lifshitz, LLP, 18 East 41st Street, New York, New York 10017, (212) 213-6222. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Eclipsys Corp. (MM) (NASDAQ:ECLP)
過去 株価チャート
から 10 2024 まで 11 2024 Eclipsys Corp. (MM)のチャートをもっと見るにはこちらをクリック
Eclipsys Corp. (MM) (NASDAQ:ECLP)
過去 株価チャート
から 11 2023 まで 11 2024 Eclipsys Corp. (MM)のチャートをもっと見るにはこちらをクリック